Molecular Epidemiology and Clinical Characterization of Carbapenemase-Producing <i>Enterobacter</i> Species From an International Cohort
Our findings demonstrate that E xiangfangensis and E hoffmannii are common species among international carbapenemase-producing Enterobacter spp, potentially linked to the clonal spread of a few predominant clones that have acquired fluoroquinolone resistance and carbapenemase-encoding plasmids.
Authors
- Robert A. Bonomo (ORCID: https://orcid.org/0000-0002-3299-894X)
- Michael J. Satlin (ORCID: https://orcid.org/0000-0003-4711-5334)
- Sandra Valderrama (ORCID: https://orcid.org/0000-0003-1833-1599)
- Yohei Doi (ORCID: https://orcid.org/0000-0002-9620-2525)
- Bettina C. Fries (ORCID: https://orcid.org/0000-0002-6847-5518)
- Blake Hanson (ORCID: https://orcid.org/0000-0003-2949-7818)
- Soraya Salcedo (ORCID: https://orcid.org/0000-0003-2110-424X)
- Jianping Jiang (ORCID: https://orcid.org/0000-0002-1066-6362)
- Angelique E Boutzoukas (ORCID: https://orcid.org/0000-0002-9477-1492)
- Carol Hill (ORCID: https://orcid.org/0000-0001-6254-6867)
- César A. Arias (ORCID: https://orcid.org/0000-0001-9054-9774)
- Henry F. Chambers (ORCID: https://orcid.org/0000-0001-5317-4491)
- Paul Anantharajah Tambyah (ORCID: https://orcid.org/0000-0003-0405-771X)
- Barry N. Kreiswirth (ORCID: https://orcid.org/0000-0002-0243-131X)
- Vance G. Fowler (ORCID: https://orcid.org/0000-0002-8048-0897)
- Gregory Weston (ORCID: https://orcid.org/0000-0003-1801-6628)
- David van Duin (ORCID: https://orcid.org/0000-0003-4784-3227)
- Scott Evans (ORCID: https://orcid.org/0000-0003-3186-172X)
- Liang Chen (ORCID: https://orcid.org/0000-0001-5845-2235)
- Zhengyin Liu (ORCID: https://orcid.org/0000-0003-1669-8848)
- Lauren Komarow
- Eric Cober
Institutions
- University of North Carolina at Chapel Hill (US)
- Houston Methodist (US)
- Albert Einstein College of Medicine (US)
- Cleveland Clinic (US)
- Montefiore Medical Center (US)
- Universidad del Norte (CO)
- Fujita Health University (JP)
- National University of Singapore (SG)
- University of Pittsburgh (US)
- Duke University (US)
- University of California, San Francisco (US)
- George Washington University (US)
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Cornell University (US)
- Cleveland Foundation (US)
- Peking Union Medical College Hospital (CN)
- Stony Brook School (US)
- Clinical Research Institute (US)
- Methodist Hospital (US)
- Universidad Simón Bolívar (CO)
- Hackensack Meridian Health (US)
- Hospital Universitario San Ignacio (CO)
- Center for Discovery (US)
- The University of Texas Health Science Center (US)
- Weill Cornell Medicine (US)
- Case Western Reserve University (US)
- Stony Brook University (US)
- The University of Texas Health Science Center at Houston (US)
Publication Details
- Journal
- The Journal of Infectious Diseases
- Published
- 2024-12-12
- DOI
- https://doi.org/10.1093/infdis/jiae616
- Citations
- 1
- Primary Topic
- Antibiotic Resistance in Bacteria
- Type
- article
- Field-Weighted Citation Impact
- 0.17
Funders
- U.S. Department of Veterans Affairs
- Eli Lilly and Company
- Pfizer
- AstraZeneca
- Sanofi
- World Health Organization
- Gilead Sciences
- Biogen
- Teva Pharmaceutical Industries
- Infectious Diseases Society of America
- Alexion Pharmaceuticals
- University of Miami
- Wayne State University
- University of Pennsylvania
- Cleveland Clinic
- Cleveland Clinic Foundation
- AtriCure
- University of Pittsburgh
- Case Western Reserve University
- Regeneron Pharmaceuticals
- NorthShore University HealthSystem
- Ochsner Health
- Apellis Pharmaceuticals
- Moderna
- Meiji Seika Pharma
- Zhejiang University
- Astellas Pharma
- Shionogi
- Peking Union Medical College Hospital
- Huashan Hospital
- Peking Union Medical College
- Wockhardt
- Stony Brook University
- National Institutes of Health
- Centers for Disease Control and Prevention
- Genentech
- University of California, Los Angeles
- Weill Cornell Medical College
- Medical Center, University of Pittsburgh
- Allergan
- University of North Carolina at Chapel Hill
- Chugai Pharmaceutical
- National Institute of Allergy and Infectious Diseases
- Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases